(Press-News.org) The beta-blocker propranolol appears to be associated with reducing the size and color of hemangiomas of the head and neck in a pediatric population, according to a report in the May issue of Archives of Otolaryngology–Head and Neck Surgery, one of the JAMA/Archives journals.
According to background information in the article, hemangiomas are tumors that appear by the age of 2 months, affecting up to 10 percent of full-term white infants. These lesions can be benign, or can affect functions such as the ability to see or on occasion can be life-threatening if they occur in areas such as airways. Although 70 percent of infantile hemangiomas regress by age 7 years, they may leave behind scars or fibrous fatty tissue. Oral corticosteroids have long been the treatment of choice for this condition, although they may be associated with some significant adverse effects. Three years ago, researchers learned that propranolol could serve as a treatment for hemangiomas in babies, and formal studies of the drug were then launched.
Carine Fuchsmann, M.D., from Hospices Civils de Lyon in Bron , France and colleagues reviewed the records of 39 children treated with propranolol for head and neck hemangiomas that had complications, threatened function or appearance or occurred in life-threatening locations. The assessment included clinical examinations, photographs, and echographic evaluations of the tumors. In 16 patients, previous treatment was either unsuccessful or associated with relapses.
In 37 of the hemangiomas, propranolol therapy was associated with improvement within two weeks. Overall, the authors note, "improvement was not only in the size but also in the quality of the lesion, which flattened and changed color." This included 26 tumors that would not otherwise have been appropriate for treatment with corticosteroids. In six cases, following treatment the tumors recurred, but another course of the drug was effective. Five patients were switched to another beta-blocker due to sleep disturbances.
The authors point out that in some patients the drug may be better tolerated than corticosteroids, and that it can be particularly helpful for "treatment of hemangiomas in locations that previously did not benefit from medical therapy because of possible adverse effects." They call for further studies to establish dosing and treatment-cessation protocols, and also to establish whether other beta-blockers can be acceptable substitutes.
###
(Arch Otolaryngol Head Neck Surg. 2011;137[5]:471-478. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To contact Tessa A. Hadlock, M.D., call Vannessa Carrington at (617) 573-3341 or e-mail Vannessa_Carrington@meei.harvard.edu.
For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail mediarelations@jama-archives.org.
Propranolol associated with improvement in size and color of head and neck hemangiomas in children
2011-05-17
ELSE PRESS RELEASES FROM THIS DATE:
Nasal steroid spray may not help resolve dysfunction of the ear's eustachian tubes
2011-05-17
For patients with eustachian tube dysfunction (ETD), steroids administered by a nasal spray may be ineffective, according to a report in the May issue of Archives of Otolaryngology–Head and Neck Surgery, one of the JAMA/Archives journals.
The eustachian tubes connect the middle ear, the upper part of the throat and the ends of the nasal passages. Eustachian tube dysfunction may contribute to fluid collection in the middle ear (otitis media with effusion, or OME) or negative middle ear pressure (NMEP). Presently there is no gold-standard single treatment for this condition, ...
Employees don't always share well with others, says new paper exposing 'knowledge hiding'
2011-05-17
Toronto - Why isn't knowledge transfer happening more often in companies spending money on it?
Maybe it's because their staff don't always want to share.
"We've had years of research in organizations about the benefits of knowledge-sharing but an important issue is the fact that people don't necessarily want to share their knowledge," says David Zweig, a professor of organizational behaviour and human resources management at the University of Toronto's Rotman School of Management and the University of Toronto at Scarborough.
His paper, co-authored with Catherine ...
Surgical procedure appears to enhance smiles in children with facial paralysis
2011-05-17
Transferring a segment of muscle from the thigh appears to help restore the ability to smile in children with facial paralysis just as it does in adults, according to a report in the May issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals. The article is part of a theme issue focusing on facial plastic surgery in the pediatric population.
Facial paralysis often disrupts the ability to smile. In pediatric patients, this can be especially problematic, according to background information in the article. Surgery to repair the affected area may generate ...
Freedom in the swamp: Unearthing the secret history of the Great Dismal Swamp
2011-05-17
It's the year 1800. You're a slave in southeast Virginia. You manage to escape. Your freedom is only going to last as long as you can hide. Where do you go?
Would you believe the Great Dismal Swamp? According to Dan Sayers, assistant professor of anthropology and an historical archaeologist at American University, that's exactly where you could have gone for immediate sanctuary.
"There are interesting parallels. What was once more of a human refuge is now a natural refuge," said Sayers of the swamp, which officially became the Great Dismal Swamp National Wildlife ...
Abcc10 may be effective in extending the effectiveness of anticancer drugs
2011-05-17
PHILADELPHIA, PA (May 16, 2011)––Today's anticancer drugs often work wonders against malignancies, but sometimes tumors become resistant to the effects of such drugs, and treatment fails. Medical researchers would like to find ways of counteracting such resistance, but first they must understand why and how it happens. New findings by Fox Chase Cancer Center researchers identify one protein, Abcc10 (also known as Mrp7), as being intimately involved in resistance to certain drugs used to treat breast, ovarian, lung, and other cancers. The results suggest that blunting the ...
Duke-NUS researchers identify new cell that attacks dengue virus
2011-05-17
Durham, N.C., and Singapore – Mast cells, which can help the body respond to bacteria and pathogens, also apparently sound the alarm around viruses delivered by a mosquito bite, according to researchers at Duke-NUS Graduate Medical School in Singapore.
"It appears the mast cells are activated and call immune system cells to the skin where they clear infection, which limits the spread of infection in the host," said lead researcher Ashley St. John, a Research Fellow with Duke-NUS in the Program in Emerging Infectious Diseases, and the Duke Department of Pathology in Durham, ...
Will global climate change enhance boreal forest growth?
2011-05-17
With an increasingly warmer climate, there is a trend for springs to arrive earlier and summers to be hotter. Since spring and summer are the prime growing seasons for plants—when flowers bloom and trees increase in girth and height—do these climate changes mean greater seasonal growth for plants? This is a critical question for forest management, especially in the boreal region—an area particularly sensitive to the effects of climate change.
Dr. Jian-Guo Huang, currently a post-doc at the University of Alberta, and colleagues from the University of Quebec at Montreal ...
Detecting lung cancer early
2011-05-17
Scientists working with Professor Dr. Joachim L. Schultze have identified over 480 molecules whose concentration in the blood changes when a person develops lung cancer. These molecules are present in the blood cells either in increased or decreased quantities. "In lung cancer patients, typical patterns which can be detected with a measuring program thus emerge", explains Prof. Schultze. The molecules are nucleic acids which form in the body when certain genes are transcribed.
The changes in the blood also occur if the tumor is still in a very early stage. In lung cancer, ...
Younger doctors prescribe more drugs to reduce heart risk but offer less lifestyle advice
2011-05-17
Patients with heart disease risks are more likely to be prescribed cardiovascular (CV) drugs if they see a younger doctor and recommended to change their lifestyle if they see an older doctor, according to research in the June issue of IJCP, the International Journal of Clinical Practice.
Italian researchers studied the attitudes and prescribing trends of 1,078 family doctors, cardiologists and diabetologists, together with clinical data on 9,904 of their outpatients, after inviting the doctors to take part in an educational training programme on managing CV risk.
"While ...
Aggressive male mating behavior can endanger species
2011-05-17
Aggressive male mating behavior might well be a successful reproductive strategy for the individual but it can drive the species to extinction, an international research team headed by evolutionary biologist Daniel Rankin from the University of Zurich has demonstrated in a mathematical model.
Evolutionary biologists have long debated whether the behavior of the individual is able to influence processes on a population or species level. The possibility of selection at species level is still contro-versial. Using a mathematical model, an international team of researchers ...